Therapies for Down Syndrome Regression Disorder | MicrobiomeTrials← Back to trialsNCT05662228
Therapies for Down Syndrome Regression Disorder
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2023-06-29Est. Completion: 2026-05-05
Enrollment target: 66 participants Locations- Children's Hospital Los Angeles, Los Angeles, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
Other microbiome trials you might be interested in
Overweight and Obese Adults
Obesity is a complex disease and a major risk factor for cardiovascular and metabolic disorders, particularly atheroscle…
Istanbul, Turkey (Türkiye)Est. completion Sep 30, 2026
Down Syndrome Regression Disorder (DSRD)Down Syndrome (Trisomy 21)Neuroinflammatory / Neuropsychiatric Disorder
The goal of this clinical trial is to evaluate whether the monoclonal antibody ublituximab can treat Down Syndrome Regre…
Los Angeles, United StatesEst. completion Oct 1, 2030
The gluteus maximus overlies the piriformis muscle and forms a broad fascial interface with it. Restricted movement, inc…
Istanbul, Turkey (Türkiye)Est. completion Jul 2027